nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Conjugated Estrogens—osteoporosis	0.163	0.216	CbGbCtD
Doxycycline—SLC22A11—Estradiol—osteoporosis	0.143	0.189	CbGbCtD
Doxycycline—SLC22A8—Conjugated Estrogens—osteoporosis	0.0947	0.125	CbGbCtD
Doxycycline—SLC22A8—Estradiol—osteoporosis	0.0831	0.11	CbGbCtD
Doxycycline—SLC22A6—Conjugated Estrogens—osteoporosis	0.0659	0.0874	CbGbCtD
Doxycycline—MMP13—periosteum—osteoporosis	0.0393	0.763	CbGeAlD
Doxycycline—CYP3A4—Estropipate—osteoporosis	0.0372	0.0493	CbGbCtD
Doxycycline—CYP3A4—Calcitriol—osteoporosis	0.0372	0.0493	CbGbCtD
Doxycycline—CYP3A4—Ergocalciferol—osteoporosis	0.0298	0.0394	CbGbCtD
Doxycycline—CYP3A4—Raloxifene—osteoporosis	0.0248	0.0329	CbGbCtD
Doxycycline—CYP3A4—Ethinyl Estradiol—osteoporosis	0.024	0.0318	CbGbCtD
Doxycycline—CYP3A4—Cholecalciferol—osteoporosis	0.0192	0.0254	CbGbCtD
Doxycycline—CYP3A4—Conjugated Estrogens—osteoporosis	0.0176	0.0233	CbGbCtD
Doxycycline—CYP3A4—Estradiol—osteoporosis	0.0155	0.0205	CbGbCtD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—CTSK—osteoporosis	0.00574	0.03	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—CTSK—osteoporosis	0.005	0.0261	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—PTH1R—osteoporosis	0.0047	0.0246	CbGpPWpGaD
Doxycycline—MMP7—uterus—osteoporosis	0.00429	0.0832	CbGeAlD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—CTSK—osteoporosis	0.00419	0.0219	CbGpPWpGaD
Doxycycline—MMP8—bone marrow—osteoporosis	0.00412	0.0799	CbGeAlD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—CTSK—osteoporosis	0.00405	0.0211	CbGpPWpGaD
Doxycycline—MMP1—uterus—osteoporosis	0.00378	0.0734	CbGeAlD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—COL1A2—osteoporosis	0.00365	0.0191	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—CTSK—osteoporosis	0.00365	0.0191	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—CTSK—osteoporosis	0.00353	0.0184	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—CTSK—osteoporosis	0.00323	0.0169	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGA—osteoporosis	0.00308	0.0161	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—osteoporosis	0.00298	0.0156	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—COL1A2—osteoporosis	0.00294	0.0154	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—COL1A2—osteoporosis	0.00292	0.0153	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—COL1A2—osteoporosis	0.00284	0.0148	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NFATC1—osteoporosis	0.00283	0.0148	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—CTSK—osteoporosis	0.00282	0.0147	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—COL1A1—osteoporosis	0.00281	0.0147	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGB—osteoporosis	0.0028	0.0147	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—osteoporosis	0.00258	0.0135	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CTSK—osteoporosis	0.00253	0.0132	CbGpPWpGaD
Doxycycline—Minocycline—IL1B—osteoporosis	0.00249	1	CrCbGaD
Doxycycline—MMP13—Endochondral Ossification—PTH—osteoporosis	0.00247	0.0129	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—LRP5—osteoporosis	0.00242	0.0127	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—ALPL—osteoporosis	0.00233	0.0122	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—LRP6—osteoporosis	0.00232	0.0121	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—IBSP—osteoporosis	0.00229	0.012	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—ALPL—osteoporosis	0.00227	0.0119	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—COL1A1—osteoporosis	0.00226	0.0118	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—COL1A1—osteoporosis	0.00224	0.0117	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—ALPL—osteoporosis	0.0022	0.0115	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—COL1A1—osteoporosis	0.00218	0.0114	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—PTHLH—osteoporosis	0.00205	0.0107	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—P4HB—osteoporosis	0.00204	0.0107	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—COL1A2—osteoporosis	0.002	0.0105	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.002	0.0105	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—P4HB—osteoporosis	0.00197	0.0103	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—COL1A2—osteoporosis	0.00195	0.0102	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—COL1A2—osteoporosis	0.00194	0.0101	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CTSK—osteoporosis	0.00185	0.00966	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—COL1A2—osteoporosis	0.00179	0.00935	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CTSK—osteoporosis	0.00178	0.00933	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—IGF1—osteoporosis	0.00171	0.00892	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—NFATC1—osteoporosis	0.0017	0.00889	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—IBSP—osteoporosis	0.00167	0.00874	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—IBSP—osteoporosis	0.00162	0.00844	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—COL1A1—osteoporosis	0.00154	0.00805	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—WNT1—osteoporosis	0.0015	0.00786	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.0015	0.00783	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—COL1A1—osteoporosis	0.00149	0.00777	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CTSK—osteoporosis	0.00143	0.00746	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.00137	0.00714	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—SPP1—osteoporosis	0.00131	0.00682	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—IBSP—osteoporosis	0.00129	0.00675	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—osteoporosis	0.00128	0.00666	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—AGER—osteoporosis	0.00125	0.00655	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—SPP1—osteoporosis	0.00124	0.00648	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AGER—osteoporosis	0.00121	0.00633	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—P4HB—osteoporosis	0.00112	0.00585	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—COL1A2—osteoporosis	0.0011	0.00574	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—COL1A2—osteoporosis	0.00108	0.00563	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CTSK—osteoporosis	0.00106	0.00555	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—ADCY5—osteoporosis	0.001	0.00523	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—FGA—osteoporosis	0.000971	0.00507	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—IRS1—osteoporosis	0.000966	0.00505	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—IRS1—osteoporosis	0.000955	0.00499	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—SPP1—osteoporosis	0.000952	0.00497	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000943	0.00493	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—osteoporosis	0.00093	0.00486	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—IRS1—osteoporosis	0.000922	0.00482	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—SPP1—osteoporosis	0.000919	0.0048	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—IGF1—osteoporosis	0.000906	0.00474	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—BMP2—osteoporosis	0.000903	0.00472	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—osteoporosis	0.000898	0.00469	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—FGB—osteoporosis	0.000883	0.00462	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—WDR1—osteoporosis	0.000878	0.00459	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—COL1A1—osteoporosis	0.000845	0.00441	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—P4HB—osteoporosis	0.000817	0.00427	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—COL1A2—osteoporosis	0.000802	0.00419	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—osteoporosis	0.000796	0.00416	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—P4HB—osteoporosis	0.000789	0.00412	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CTSK—osteoporosis	0.000774	0.00405	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—COL1A2—osteoporosis	0.000774	0.00405	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—osteoporosis	0.000761	0.00398	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—ESR1—osteoporosis	0.000753	0.00393	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—osteoporosis	0.000751	0.00392	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CTSK—osteoporosis	0.000748	0.00391	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—IRS1—osteoporosis	0.000746	0.0039	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—SPP1—osteoporosis	0.000735	0.00384	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—osteoporosis	0.000718	0.00375	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—FGA—osteoporosis	0.000708	0.0037	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAP1—osteoporosis	0.000694	0.00363	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—FGA—osteoporosis	0.000684	0.00357	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—BMP2—osteoporosis	0.000658	0.00344	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—FGB—osteoporosis	0.000644	0.00337	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—osteoporosis	0.000637	0.00333	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—BMP2—osteoporosis	0.000636	0.00332	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—P4HB—osteoporosis	0.000631	0.0033	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—FGB—osteoporosis	0.000622	0.00325	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—COL1A2—osteoporosis	0.000619	0.00323	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—COL1A1—osteoporosis	0.000616	0.00322	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	0.000609	0.00318	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CTSK—osteoporosis	0.000598	0.00312	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000597	0.00312	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—COL1A1—osteoporosis	0.000595	0.00311	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCT2—osteoporosis	0.000572	0.00299	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—osteoporosis	0.000568	0.00297	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—MGLL—osteoporosis	0.000551	0.00288	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—FGA—osteoporosis	0.000547	0.00286	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SPP1—osteoporosis	0.000547	0.00286	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—osteoporosis	0.000543	0.00284	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—BMP2—osteoporosis	0.000508	0.00266	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLEK—osteoporosis	0.000504	0.00263	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ANXA2—osteoporosis	0.000504	0.00263	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—FGB—osteoporosis	0.000497	0.0026	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoporosis	0.00049	0.00256	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—TUBA1B—osteoporosis	0.000487	0.00254	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—COL1A1—osteoporosis	0.000476	0.00249	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TLN1—osteoporosis	0.000435	0.00227	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VCL—osteoporosis	0.000429	0.00224	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	0.000407	0.00213	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SPP1—osteoporosis	0.000399	0.00208	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—osteoporosis	0.000391	0.00205	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000391	0.00204	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—RPL24—osteoporosis	0.000389	0.00203	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SPP1—osteoporosis	0.000385	0.00201	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	0.00038	0.00199	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—osteoporosis	0.000362	0.00189	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RAP1A—osteoporosis	0.000358	0.00187	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—TLN1—osteoporosis	0.000342	0.00179	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—REN—osteoporosis	0.000329	0.00172	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—FGA—osteoporosis	0.000325	0.0017	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00032	0.00167	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SPP1—osteoporosis	0.000308	0.00161	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—FGB—osteoporosis	0.000296	0.00154	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—osteoporosis	0.000294	0.00154	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000259	0.00135	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000256	0.00134	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000254	0.00133	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000251	0.00131	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—osteoporosis	0.00024	0.00125	CbGpPWpGaD
Doxycycline—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000239	0.00125	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—osteoporosis	0.000236	0.00123	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—osteoporosis	0.000235	0.00123	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000212	0.00111	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000206	0.00108	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—osteoporosis	0.000205	0.00107	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000195	0.00102	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000184	0.000959	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—osteoporosis	0.000175	0.000914	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—osteoporosis	0.000169	0.000883	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000165	0.000862	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000163	0.00085	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—osteoporosis	0.000135	0.000706	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IGF1—osteoporosis	0.000134	0.000699	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000133	0.000697	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000132	0.000688	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—LEP—osteoporosis	0.000127	0.000666	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—POMC—osteoporosis	0.000109	0.000572	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000109	0.000571	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000108	0.000565	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000108	0.000563	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGF1—osteoporosis	0.000105	0.00055	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.59e-05	0.000501	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—osteoporosis	8.02e-05	0.000419	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.01e-05	0.000419	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.31e-05	0.000382	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.5e-05	0.000339	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.1e-05	0.000319	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.74e-05	0.0003	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.66e-05	0.000296	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—POMC—osteoporosis	3.45e-05	0.00018	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PKM—osteoporosis	3.25e-05	0.00017	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—FDPS—osteoporosis	3.25e-05	0.00017	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PGLS—osteoporosis	3.09e-05	0.000161	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GPD2—osteoporosis	3.09e-05	0.000161	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ATIC—osteoporosis	2.82e-05	0.000147	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PNP—osteoporosis	2.82e-05	0.000147	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA2—osteoporosis	2.4e-05	0.000125	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—OXCT1—osteoporosis	2.4e-05	0.000125	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MGLL—osteoporosis	2.34e-05	0.000122	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—IDH2—osteoporosis	1.99e-05	0.000104	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.87e-05	9.77e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ACP5—osteoporosis	1.82e-05	9.5e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TPI1—osteoporosis	1.69e-05	8.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—P4HB—osteoporosis	1.59e-05	8.31e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GAPDH—osteoporosis	1.56e-05	8.15e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RAP1A—osteoporosis	1.52e-05	7.94e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ENO1—osteoporosis	1.23e-05	6.42e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PSMA2—osteoporosis	1.21e-05	6.32e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PSMA5—osteoporosis	1.21e-05	6.32e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.82e-06	5.13e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ADCY5—osteoporosis	8.02e-06	4.19e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GPX1—osteoporosis	8e-06	4.18e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTHFR—osteoporosis	7.38e-06	3.86e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—POMC—osteoporosis	5.9e-06	3.08e-05	CbGpPWpGaD
